XuanZhu Pharma Funding: $239M Raised, Series B (2021)
XuanZhu Pharma is based in Shijiazhuang, China. It has raised $239M in total funding. Latest round: Series B.
XuanZhu Pharma funding overview
XuanZhu Pharma is based in Shijiazhuang, China. XuanZhu Pharma has raised $239M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2021. The round record for XuanZhu Pharma runs through 2021; nothing later has been disclosed. Investors on record include Sunshine Life Insurance Corp., State Development and Investment Corp., CMG-SDIC Capital Co. Ltd.. 3 distinct backers are named across the disclosed rounds.
XuanZhu Pharma at a glance
Total raised
$239M
Latest round
Series B
Latest round date
January 2021
Headquarters
Shijiazhuang, China
Notable investors
Sunshine Life Insurance Corp., State Development and Investment Corp., CMG-SDIC Capital Co. Ltd.
Frequently asked about XuanZhu Pharma funding
How much has XuanZhu Pharma raised?
XuanZhu Pharma has raised $239M in total disclosed funding across the rounds on record.
Who has invested in XuanZhu Pharma?
Sunshine Life Insurance Corp., State Development and Investment Corp., CMG-SDIC Capital Co. Ltd. are named among the investors backing XuanZhu Pharma.
What was the latest XuanZhu Pharma funding round?
The most recent disclosed round is a Series B, announced in January 2021.
Where is XuanZhu Pharma based?
XuanZhu Pharma is based in Shijiazhuang, China.
When did XuanZhu Pharma last raise?
The last disclosed XuanZhu Pharma round closed in January 2021 at Series B.
XuanZhu Pharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Shijiazhuang below to benchmark round size and investor mix.
